Megestrol Acetate

CAS 595-33-5 8 current records 5 historicalSmall Molecule

Who holds supplier records for Megestrol Acetate? 8 organisations hold a current record for Megestrol Acetate: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), Italy (1), United States (1) and Netherlands (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Megestrol Acetate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/megestrol-acetate

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Megestrol Acetate. Country is the organisation's recorded country, not necessarily the manufacturing site.

China3Italy1United States1Netherlands1Country not recorded for 2
Need Megestrol Acetate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Megestrol Acetate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
XIANJU SYNSEA BIOPHA CO. LTD. TaizhouCN
CEP 2020-293 - Rev 01
Megestrol acetate, Micronised
Mar 2026—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2002-181 - Rev 10
Megestrol acetate, Micronised and fine powder
Jan 2026Inspected Jul 2026
Italy
ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2012-010 - Rev 05
Megestrol acetate
Dec 2025—
TAPI NL B.V. AmsterdamNL
CEP 2009-086 - Rev 02
Megestrol acetate
Mar 2025—
Taizhou Taifa Pharmaceuticals Co., Ltd. XianjuCN
R1-CEP 2012-011 - Rev 00
Megestrol acetate
Nov 2018—
Pharmacia & Upjohn Company KalamazooUS
R1-CEP 2008-020 - Rev 01
Megestrol acetate, Micronised
Sept 2014—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Megestrol Acetate are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • United States · Inactive DMF 12157 · filed Oct 1996
  • SOCIETA ITALIANA CORTICOSTEROIDI SPA
    Inactive DMF 6673 · filed Nov 1986
  • Germany · Inactive DMF 5296 · filed Mar 1984
  • GLAXO LABORATORIES SA
    Inactive DMF 2494 · filed Jul 1975
  • SYNTEX USA INC
    Inactive DMF 1738 · filed Jun 1971

Overview

Megestrol Acetate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201139).

Chemical identity

IUPAC name
[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
Canonical SMILES
CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
InChIKey
RQZAXGRLVPAYTJ-GQFGMJRRSA-N
Synonyms
5071, BDH 1298, BDH-1298, Chronopil, Megace, Megace es, Megesterol acetate, Megestrol, Megestrol 17.alpha.-acetate, Megestrol acetate, NSC-71423, SC 10363

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Progestin
Chemical structure
Progesterone Congeners

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Megestrol Acetate?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Megestrol Acetate: Farmabios S.p.A. (Italy), Pharmacia & Upjohn, Inc. (United States), TAIZHOU TAIFA PHARMACEUTICALS CO LTD, TAPI NL BV (Netherlands), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD, JIANGSU GRAND XIANLE PHARMACEUTICAL CO LTD (China), ZHEJIANG XIANJU YANGGUANG BIOPRODUCTS CO LTD (China) and XIANJU SYNSEA BIOPHA CO. LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Megestrol Acetate Drug Master Files are active?

Farmabios S.p.A. (DMF 12662), Pharmacia & Upjohn, Inc. (DMF 1817), TAIZHOU TAIFA PHARMACEUTICALS CO LTD (DMF 24583), TAPI NL BV (DMF 12687), ZHEJIANG XIANJU PHARMACEUTICAL CO LTD (DMF 24592), JIANGSU GRAND XIANLE PHARMACEUTICAL CO LTD (DMF 27596) and ZHEJIANG XIANJU YANGGUANG BIOPRODUCTS CO LTD (DMF 35601). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Megestrol Acetate records mean?

5 organisations have only inactive Type II DMFs for Megestrol Acetate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Megestrol Acetate have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Megestrol Acetate on the EDQM register, including XIANJU SYNSEA BIOPHA CO. LTD. Taizhou (CN), FARMABIOS S.p.A Gropello Cairoli (IT), ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), TAPI NL B.V. Amsterdam (NL), Taizhou Taifa Pharmaceuticals Co., Ltd. Xianju (CN) and Pharmacia & Upjohn Company Kalamazoo (US). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Megestrol Acetate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Megestrol Acetate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.